Scientists explore combination therapy targeting AURKA and AURKB proteins to combat triple-negative breast cancer, focusing on health disparities in women of African ancestry.
Exploring the clinical and biological differences in breast cancer between Nigerian and UK women, focusing on molecular subtypes and genetic factors.